Corp (NYSE:OCX) reported a net loss per share of 10 cents for the second quarter of 2019, narrower than the net loss per share of 12 cents for the second quarter of 2018.
Release date- 14082019 - ALAMEDA - OncoCyte
Corporation (NYSE American: OCX), a developer of novel, non-invasive tests for the early detection of cancer, today reported financial and operating results for the second quarter ended June 30, 2019and provided a corporate update.
M2 EQUITYBITES-July 3, 2019-BioTime announces sale of 2,250,000 common shares in OncoCyte
Global Banking News-July 3, 2019-BioTime announces sale of 2,250,000 common shares in OncoCyte
Three-dimensional structure of oncocyte
mitochondria in human salivary glands: a scanning electron microscope study.
(NYSE American: AST) and OncoCyte
Corporation (NYSE American: OCX), and a private company, AgeX Therapeutics, Inc.
Human high and low metastatic potential HCCs (MHCC97-H and MHCC97-L) tumorous nodes, which were cultured in vivo through subcutaneous vaccination in mice bodies with favorable growth, were prepared into oncocyte
patches through sterile operation and inoculated in the subcutaneous armpits of the mice with puncture needles.
He is currently an independent member of the Board of Directors of Oncocyte
"It is one of the markers in what we call PanC-Dx," says West, developed by BioTime and subsidiary Oncocyte
for the detection of various human cancers.
Scientists at BioTime's subsidiaries Oncocyte
Corporation and ReCyte Therapeutics plan to apply this technology in the development of innovative medical products for cancer and vascular diseases.
Another subsidiary, OncoCyte
Corporation, focuses on the therapeutic applications of stem cell technology in cancer.
However, apoptosis of the parenchymal cells and the decrease of the gland weight were slight.27 Mahay S et al reported infiltration of lipids and mast cells of the parotid gland and decrease in amylase release and cytosolic Ca2+ signals with ageing.28 Furthermore, Martinez-Madrigal F et al re-ported the ageing changes including oncocyte
prolif-eration, fatty infiltration, squamous and mucous meta-plasia, hyperplasia, atrophy, and regeneration.29 In addition, Scott J.